2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neutropenia
1
Neoplasms
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
pegfilgrastim
30
Filgrastim
29
Cyclophosphamide
10
pegylated granulocyte colony-stimulating factor
8
Docetaxel
8
Etoposide
7
Cytarabine
7
Ciprofloxacin
6
Cefepime
6
Vancomycin
5
Leucovorin
5
Fluorouracil
5
eflapegrastim
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Peripheral Blood Stem Cell Transplantation
3
Mitoxantrone
3
Methotrexate
3
Levofloxacin
3
Irinotecan
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Caspofungin
3
Carboplatin
3
Amikacin
3
trifluridine tipiracil drug combination
2
plerixafor
2
liposomal amphotericin B
2
Vincristine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Antiviral Agents
×
Clear all
NCT01821456
2013-04-01
CoCoNut
University Hospital of Cologne
Recruiting
100,000 enrolled